-
VNDA Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Vanda Pharmaceuticals (VNDA)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 102.79 mm | 102.79 mm | 102.79 mm | 102.79 mm | 102.79 mm | 102.79 mm |
Cash burn (monthly) | (no burn) | 2.79 mm | 3.43 mm | 3.39 mm | 605.67 k | 1.31 mm |
Cash used (since last report) | n/a | 5.78 mm | 7.09 mm | 7.01 mm | 1.25 mm | 2.72 mm |
Cash remaining | n/a | 97.01 mm | 95.69 mm | 95.77 mm | 101.53 mm | 100.07 mm |
Runway (months of cash) | n/a | 34.7 | 27.9 | 28.3 | 167.6 | 76.2 |
13F holders | Current |
---|---|
Total holders | 146 |
Opened positions | 23 |
Closed positions | 28 |
Increased positions | 53 |
Reduced positions | 43 |
13F shares | Current |
---|---|
Total value | 193.36 bn |
Total shares | 43.11 mm |
Total puts | 28.70 k |
Total calls | 33.81 k |
Total put/call ratio | 0.8 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 9.10 mm | $43.61 bn |
Renaissance Technologies | 3.85 mm | $18.46 bn |
Vanguard | 3.51 mm | $16.80 bn |
Dimensional Fund Advisors | 2.49 mm | $11.92 bn |
Tang Capital Management | 2.35 mm | $11.27 bn |
Acadian Asset Management | 1.90 mm | $9.10 mm |
Geode Capital Management | 1.45 mm | $6.95 bn |
MS Morgan Stanley | 1.34 mm | $6.42 bn |
STT State Street | 1.18 mm | $5.67 bn |
Schroder Investment Management | 1.04 mm | $4.96 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
28 Feb 25 | Mihael Hristos Polymeropoulos | Common Stock | Buy | Acquire P | No | No | 4.76 | 10,000 | 47.60 k | 2,361,730 |
27 Feb 25 | Mihael Hristos Polymeropoulos | Common Stock | Buy | Acquire P | No | No | 4.76 | 10,000 | 47.60 k | 2,351,730 |
26 Feb 25 | Mihael Hristos Polymeropoulos | Common Stock | Buy | Acquire P | No | No | 4.78 | 5,000 | 23.90 k | 2,341,730 |
26 Feb 25 | Mihael Hristos Polymeropoulos | Common Stock | Buy | Acquire P | No | No | 4.75 | 5,000 | 23.75 k | 2,336,730 |
25 Feb 25 | Mihael Hristos Polymeropoulos | Common Stock | Buy | Acquire P | No | No | 4.464 | 10,000 | 44.64 k | 2,331,730 |
21 Feb 25 | Kevin Patrick Moran | Common Stock | Buy | Acquire P | No | No | 4.3894 | 2,000 | 8.78 k | 355,763 |